Labor Day Holiday Shipment Schedules - Insights
Due to the Labor Day holiday (recognized on Monday, September 4th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen viability and avoid turnaround time delays, follow the guidelines...
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
Christmas and New Year's specimen shipment alert - Insights
Due to the Christmas and New Year's holiday's (recognized on Saturday, December 25th, and Saturday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and...
MCL Hereditary Peripheral Neuropathy Flyer MC2775648
MCL Hereditary Peripheral Neuropathy Flyer HEREDITARY PERIPHERAL NEUROPATHY SIMPLIFY IMPROVE DIAGNOSIS PHENOTYPIC FOCUSED TESTING Hereditary peripheral neuropathies diverse group disorders
July 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
Mayo Clinic Laboratories offers a robust menu of biomarker testing to assess liver disease related to nonalcoholic and alcoholic causes. These include FibroTest-ActiTest, a first-line screening assay that uses two diagnostic scores based on...
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
meningitis-encephalitis_panel_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 11/2024 Recommended testing for patients with findings suggestive of acute (<8 days of symptoms) meningitis or encephalitis. NOTE: Not intended for patients...
CPT codes and LOINC update: December 2022 - Insights
This page includes updates posted to the site during the month of December.
Mayo Clinic Laboratory and pathology research roundup: March 22 - Insights
This Feature Includes: A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.